NCT00027443View on ClinicalTrials.gov

Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

July 31, 2007

Conditions
Myocarditis
Interventions
DRUG

Muromonab-CD3

DRUG

Cyclosporine

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER